RSA Viewpoints All RSA Viewpoints | Podcasts

Harnessing talent to realise the potential of cannabinoids and psychedelics

Rising from taboo to treatment, pharma companies are testing cannabinoids and psychedelic molecules for an increasing range of indications. The results could provide new treatments for painful diseases that are… Read more »

Read more